Category: Pharmaceuticals
Global Pharmaceuticals
-
Chicory Market By Product Type (Extract, Roasted, Instant Powder, Flour) , By Form (Powder, Cube, Liquid) By Application (Food and Beverage Industry, Dietary Supplement, Feed and Pet Food, Cosmetics and Personal Care, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2034
... Opportunity Analysis and Industry Forecast, 2024-2034 The chicory market was valued at $725.3 million in 2023, and is projected to reach $985.5 million by 2034, growing at a CAGR of 2.9% from 2024 to 2034. ... Read More
-
Global Home Infusion Therapy Market Forecast Report By Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors), Application (Anti-Infective, Hydration Therapy, Chemotherapy, Enternal Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others), Countries and Company Analysis 2024-2032
... Home Infusion Therapy Market Analysis The home infusion therapy market is anticipated to reach US$ 72.84 billion by 2032 from US$ 42.70 billion in 2023, growing at a CAGR of 6.12% between 2024 and 2032. ... Read More
-
Heart Healthy Ingredients
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Omega-3, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$12.4 Billion by the ... Read More
-
Pain Management Drugs Market By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics) , By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033 Pain Management Drugs Market The pain management drugs market was valued at $72.6 billion in 2023 ... Read More
-
Lucid Dreaming Devices Market (Device Type: Wearable Devices and Non-wearable Devices; Application: Personal Use and Therapeutics Use) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Report TMR’s report on the global lucid dreaming devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast ... Read More
-
Probiotics Market Report by Ingredient (Bacteria, Yeast), Distribution Channel (Supermarkets and Hypermarkets, Pharmacies/Drugstores, Specialty Stores, Online Stores, and Others), Application (Food and Beverages, Dietary Supplements, Animal Feed), Form (Dry, Liquid), and Region 2024-2032
... probiotics market size reached US$ 63.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 114.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.6% during 2024-2032. Rising digestive issues, ... Read More
-
Cold Chain Packaging Market Report by Product (Insulated Container and Boxes, Crates, Cold Packs, Labels, Temperature Controlled Pallet Shippers), End User (Food, Dairy, Pharmaceutical, and Others), and Region 2024-2032
... size reached US$ 27.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 68.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.52% during 2024-2032. The significant expansion in the ... Read More
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
... projected to reach USD 105 million by 2029 from USD 80 million in 2024, at a CAGR of 5.5% during the forecast period of 2024 to 2029. The market is experiencing an upward trend driven ... Read More
-
Soldier Systems
... at a CAGR of 5.0% over the analysis period 2023-2030. Personal Protection, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
mRNA Platform
... at a CAGR of -3.1% over the analysis period 2023-2030. Covid-19 Vaccine, one of the segments analyzed in the report, is expected to record a -6.1% CAGR and reach US$96.5 Billion by the end of ... Read More
-
Color Cosmetics
... at a CAGR of 4.6% over the analysis period 2023-2030. Color Cosmetics for Prestige Product Market, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$73.0 Billion ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Anti-Counterfeit Packaging
... at a CAGR of 9.3% over the analysis period 2023-2030. Mass Encoding Technology, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$109.6 Billion by the end ... Read More
-
Enteral Feeding Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Enteral Feeding Tubes, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.5 Billion ... Read More
-
Blood Pressure Monitoring and Measurement Instruments
... the year 2023, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Sphygmomanometers, one of the segments analyzed in the report, is expected to record ... Read More
-
Anti-Hypertensive Drugs
... at a CAGR of 2.8% over the analysis period 2023-2030. Calcium Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$7.2 Billion by the end ... Read More
-
Migraine Drugs
... at a CAGR of 16.1% over the analysis period 2023-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... the year 2023, is expected to reach US$57.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Stimulant Drugs, one of the segments analyzed in the report, is expected to ... Read More
-
Chiropractic Care
... at a CAGR of 3.6% over the analysis period 2023-2030. Relief Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$25.6 Billion by the end of ... Read More
-
Pharma And Biotech CRM Software Global Market Report 2024
... And Medium Enterprise (SMEs)4) By Industry: Pharmaceuticals; BiotechCovering: Oracle Corporation; Salesforce.com Inc.; IQVIA Holdings Inc.; Trueblue Inc.; Cirrius Solutions Inc. Pharma And Biotech CRM Software Global Market Report 2024 from The Business Research Company provides ... Read More
-
2024 Global Ophthalmic Goods Manufacturing, Nsk, Total Products Markets (2030 Outlook)
... Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. The ... Read More
-
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material
... 2024-2035. Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed ... Read More
-
Super Generics Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Therapeutic Area
... These refined pharmacological interventions are often termed as complex generics or value-added generics and serve as generic alternatives to their branded counterparts. Notably, in 2022, the US FDA sanctioned over 32,000 generic drug products, with ... Read More
-
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications
... during the forecast period 2024-2035. Rare kidney diseases encompass a spectrum of conditions, accounting to at least 150 distinct disorders. In Europe, a condition is deemed rare if its prevalence falls below 1 in 2000 ... Read More
-
Tuberculosis Therapeutics
... at a CAGR of 2.7% over the analysis period 2023-2030. Active TB Therapeutics, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$654.3 Million by the end ... Read More
Research Assistance
